Learn More
Medchemexpress LLC 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8H-pyrimido[4,5-b]diazepin-2-yl)amino]-3-methoxy-... | 1062243-51-9 | MFCD22665717 | 99.5% | 543.61 g·mol⁻1 | C27H35F2N7O3 | 10 MG

Supplier: Medchemexpress LLC HY1516110MG
Ro3280 is a potent, highly selective small-molecule inhibitor of Polo-like kinase 1 (PLK1) used in preclinical research to study cell cycle regulation and anticancer mechanisms. It exhibits low-nanomolar biochemical potency and demonstrated cellular activity across multiple cancer cell lines.
- Potent PLK1 inhibition with IC50 ≈ 3 nM and Kd ≈ 0.09 nM.
- Demonstrated cellular activity in multiple cancer cell lines.
- High reported purity (≈99.5%).
- Solid form, off-white to yellow appearance.
- Molecular weight 543.61 g·mol⁻1; formula C27H35F2N7O3.
- Suitable for in vitro research on PLK1 biology and anticancer mechanisms.
- Shows selectivity for PLK1 over PLK2 and PLK3.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.